Learn practical approaches to applying AI in pharmacovigilance, including quality controls, confidence indicators, auditability, and human oversight, through a live demonstration of AI-enabled case intake.
TORONTO, Oct. 14, 2026 /PRNewswire/ — Pharmacovigilance intake processes must keep pace with the growing volume and variety of incoming data. Potential adverse events and product quality complaints can arrive through a variety of sources, including emails, websites and portals, chatbots, call centers, and digital formats like xml.
While automation is becoming part of this data intake process, most pharmacovigilance teams still rely on heavily manual reviews to assess, classify and route each potential case. This webinar will explore how AI-enabled adverse event detection and intake can help teams manage this increasing volume while maintaining appropriate human oversight to drive quality.
The session will examine practical considerations for introducing AI into a regulated pharmacovigilance environment, including embedded quality checks, transparent confidence indicators, auditability and end-to-end traceability of extracted information and resulting decisions. The goal is not to replace human oversight but to automate appropriate activities and focus expert attention where it adds the most value.
A live demonstration of ElevateSafety™ and Detective, powered by Converge™ by Deloitte, will illustrate how AI-enabled detection, data structuring, quality checks and routing can support adverse event intake across diverse data sources. Whether an organization is evaluating AI for the first time or benchmarking an existing approach, this session will provide a practical, grounded view of what’s possible today for pharmaceutical and life sciences safety operations.
Register for this webinar to learn how pharmacovigilance teams can use AI to manage rising data volumes without sacrificing quality, compliance or human accountability.
Join Cyle Connell, Associate Vice President of Product Management for ElevateSafety™, Deloitte Consulting LLP; and Ellen O’Dea, Senior Manager, Deloitte Consulting LLP, for the live webinar on Wednesday, October 28, 2026, at 1pm EDT (10am PDT).
For more information, or to register for this event, visit Improve Pharmacovigilance Quality with AI-Enabled Case Intake.
ABOUT XTALKS
Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what’s next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
*Please see www.deloitte.com/us/about for a detailed description of their legal structure.
Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: skumar@xtalks.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/improve-pharmacovigilance-quality-with-ai-enabled-case-intake-upcoming-webinar-featuring-deloitte-leaders-hosted-by-xtalks-302908574.html
SOURCE Xtalks
